We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+4.1%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$784M
AUM Growth
-$6.75M
(-0.85%)
Cap. Flow
-$30.4M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
33.42%
Holding
214
New
17
Increased
82
Reduced
79
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
New York Times
NYT
|
+$4.05M |
| 2 |
Teladoc Health
TDOC
|
+$2.31M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$1.56M |
| 5 |
Equifax
EFX
|
+$1.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$7.11M |
| 2 |
Xylem
XYL
|
+$6.16M |
| 3 |
Fortive
FTV
|
+$4.32M |
| 4 |
Illumina
ILMN
|
+$4.13M |
| 5 |
IPG Photonics
IPGP
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.47% |
| 2 | Technology | 20.67% |
| 3 | Industrials | 12.88% |
| 4 | Financials | 10.93% |
| 5 | Communication Services | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
PepsiCo
PEP
$188B
| $3.06M | 0.39% |
28,152
+2,609
| +10% | +$269K |
|
52
McDonald's
MCD
$192B
| $3.03M | 0.39% |
19,356
+89
| +0.5% | +$14.4K |
|
53
Thermo Fisher Scientific
TMO
$222B
| $2.96M | 0.38% |
14,287
+29
| +0.2% | +$6.16K |
|
54
VF Corp
VFC
$5.84B
| $2.94M | 0.37% |
38,252
-3,295
| -8% | -$248K |
|
55
Verizon
VZ
$196B
| $2.82M | 0.36% |
56,034
+3,648
| +7% | +$177K |
|
56
Visa
V
$680B
| $2.8M | 0.36% |
21,108
-116
| -0.5% | -$14.9K |
|
57
Merck
MRK
$321B
| $2.78M | 0.35% |
48,018
+2,543
| +6% | +$143K |
|
58
Berkshire Hathaway Class B
BRK.B
$1.11T
| $2.65M | 0.34% |
14,211
+715
| +5% | +$139K |
|
59
State Street SPDR S&P 500 ETF Trust
SPY
$808B
| $2.5M | 0.32% |
9,209
-835
| -8% | -$225K |
|
|
NVO
60
Novo Nordisk
NVO
$206B
| $2.44M | 0.31% |
105,884
-9,236
| -8% | -$220K |
|
61
Chevron
CVX
$385B
| $2.31M | 0.3% |
18,311
+431
| +2% | +$53.5K |
|
62
Church & Dwight Co
CHD
$24.4B
| $2.26M | 0.29% |
42,515
-909
| -2% | -$44K |
|
63
NextEra Energy
NEE
$178B
| $2.23M | 0.28% |
53,456
+9,864
| +23% | +$398K |
|
64
Pfizer
PFE
$151B
| $2.17M | 0.28% |
62,891
+9,553
| +18% | +$326K |
|
65
Ormat Technologies
ORA
$7.03B
| $2.16M | 0.28% |
40,540
+7,815
| +24% | +$427K |
|
|
TWTR
66
DELISTED
Twitter, Inc.
TWTR
| $2.1M | 0.27% |
48,048
+16,670
| +53% | +$585K |
|
67
Clorox
CLX
$13B
| $2.02M | 0.26% |
14,904
+687
| +5% | +$84.8K |
|
68
Veeva Systems
VEEV
$38.6B
| $1.99M | 0.25% |
25,930
+17,450
| +206% | +$1.33M |
|
69
Chubb
CB
$134B
| $1.92M | 0.24% |
15,103
+2,139
| +16% | +$284K |
|
70
Oracle
ORCL
$417B
| $1.88M | 0.24% |
42,738
-4,909
| -10% | -$226K |
|
71
Amgen
AMGN
$224B
| $1.88M | 0.24% |
10,187
-181
| -2% | -$32K |
|
72
Honeywell
HON
$74.3B
| $1.82M | 0.23% |
14,013
-296
| -2% | -$39.4K |
|
73
DuPont de Nemours
DD
$19.4B
| $1.67M | 0.21% |
10,022
+987
| +11% | +$165K |
|
74
Truist Financial
TFC
$63.9B
| $1.65M | 0.21% |
32,680
+350
| +1% | +$18.6K |
|
|
75
Fidelity National Information Services
FIS
$22.2B
| $1.63M | 0.21% |
+15,368
| New | +$1.56M |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
HA
NIM
Reynders McVeigh Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Reynders McVeigh Capital Management held 214 positions worth $784M, down 0.85% from $791M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Reynders McVeigh Capital Management withdrew a net $30.4M in Q2 2018, closing 11 positions and reducing 79 holdings. Its most notable exit was Kroger, an estimated $1.82M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.
Against the trend, Reynders McVeigh Capital Management opened a new position in New York Times worth $4.46M.
- Reynders McVeigh Capital Management's largest Q2 2018 buy was New York Times: 172,104 shares worth $4.46M.
- Reynders McVeigh Capital Management added most to Teladoc Health in Q2 2018, an estimated $2.31M increase.
- Reynders McVeigh Capital Management's biggest Q2 2018 reduction was Procter & Gamble, cutting an estimated $7.11M.
- Reynders McVeigh Capital Management fully exited Kroger in Q2 2018, selling an estimated $1.82M.
- Reynders McVeigh Capital Management's ten largest holdings make up 33% of its $784M portfolio in Q2 2018.
- Reynders McVeigh Capital Management opened 17 new positions and closed 11 in Q2 2018.
- Reynders McVeigh Capital Management's portfolio value fell 0.85% quarter-over-quarter to $784M.
Based on Reynders McVeigh Capital Management's 13F filing for Q2 2018, filed 9 Aug 2018.